As companies evaluate potential mergers and acquisitions, joint ventures, or sale transactions, artificial intelligence (AI) must now be part of the discussion. AI can significantly impact a company’s valuation and risk...more
12/4/2025
/ Acquisitions ,
AI Act ,
Artificial Intelligence ,
Corporate Governance ,
Data Privacy ,
Data Protection ,
Data Security ,
Due Diligence ,
Intellectual Property Protection ,
Mergers ,
Popular ,
Regulatory Oversight ,
Regulatory Requirements ,
Risk Management ,
Securities and Exchange Commission (SEC) ,
Strict Product Liability ,
Trade Secrets
The USPTO recently announced that the Accelerated Examination program will be discontinued as of July 10, 2025. Given that the program has had limited use over the past decade, with fewer than 100 Accelerated Examination...more
A Senate panel has advanced three sets of bipartisan bills purportedly aimed at reforming the intellectual property (IP) landscape and lowering the cost of prescription drugs. Together, these bills seek to address issues with...more
The listing of patents in the Orange Book has an important role in intellectual property protection for pharmaceuticals. Patents listed in the Orange Book can include, without question, patents covering compositions or...more
For decades, authors and filmmakers have contemplated the challenges and opportunities presented when machines take on human-like capabilities. In 1984, James Cameron sent us the Terminator, a cyborg created by SkyNet, an...more